High-affinity mu opioid receptor ligands discovered by the screening of an exhaustively stereodiversified library of 1,5-enediols

Journal of the American Chemical Society

Volumn 124, Issue 45, 2002, Pages 13352-13353

  Harrison, Bryce A ^a   Gierasch, Tiffany Malinky ^a   Neilan, Claire ^b   Pasternak, Gavril W ^b   Verdine, Gregory L ^a  

^a HARVARD UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ENEDIOL; ALKENE DERIVATIVE; LIGAND; MU OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; LIGAND BINDING; RECEPTOR BINDING; SCREENING; STEREOCHEMISTRY; STEREOISOMERISM;

ALCOHOLS; ALKENES; COMBINATORIAL CHEMISTRY TECHNIQUES; DIPEPTIDES; KINETICS; LIGANDS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STEREOISOMERISM; SUBSTRATE SPECIFICITY;

EID: 0037073163     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja027150p     Document Type: Article

References (26)

1. (a) Mitchison, T. J. Chem. Biol. 1994, 1, 3-6.
2. (b) Schreiber, S. L. Bioorg. Med. Chem. 1998, 6, 1127-1152.
3. (a) Schreiber, S. L. Science 2000, 287, 1964-1969.
4. (b) Stockwell, B. R. Nat. Rev. Genet. 2000, 1, 116-125.
5. (a) Nicolaou, K. C.; Pfefferkorn, J. A.; Mitchell, H. J.; Roecker, A. J.; Barluenga, S.; Cao, G.-Q.; Affleck, R. L.; Lillig, J. E. J. Am. Chem. Soc. 2000, 122, 9954-9967.
6. (b) Tan, D. S.; Foley, M. A.; Shair, M. D.; Schreiber, S. L. J. Am. Chem. Soc. 1998, 120, 8565-8566.
7. (c) Bunin, B. A.; Plunkett, M. J.; Ellman, J. A.; Bray, A. M. New J. Chem. 1997, 21, 125-130.
8. (a) Gierasch, T. M.; Chytil, M.; Didiuk, M. T.; Park, J. Y.; Urban, J. J.; Nolan, S. P.; Verdine, G. L. Org. Lett. 2000, 2, 3999-4002.
9. (b) Harrison, B. A.; Verdine, G. L. Org. Lett. 2001, 3, 2157-2159.
10. (c) Annis, D. A.; Helluin, O.; Jacobsen, E. N. Angew. Chem., Int. Ed. 1998, 37, 1907-1909.
11. (d) Paterson, I.; Scott, J. P. J. Chem. Soc., Perkins Trans. 1 1999, 1003-1014.
12. (e) Paterson, I.; Channon, J. A. Tetrahedron Lett. 1992, 33, 797-800.
13. (a) Dooley, C. T.; Houghten, R. A. Biopolymers 1999, 51, 379-390.
14. (b) Hruby, V. J.; Agnes, R. S. Biopolymers 1999, 51, 391-410.
15. (a) Standifer, K. M.; Pasternak, G. W. Cell Signalling 1997, 9, 237-248.
16. (b) Pasternak, G. W. Life Sci. 2001, 68, 2213-2219.
17. (a) Zadina, J. E.; Hackler, L.; Ge, L.-J.; Kastin, A. J. Nature 1997, 386, 499-502.
18. (b) Zadina, J. E.; Martin-Schild, S.; Gerall, A. A.; Kastin, A. J.; Hackler, L.; Ge, L.-J.; Zhang, X. Ann. N.Y. Acad. Sci. 1999, 897, 136-144.
19. (a) Kingsbury, C. L.; Mehrman, S. J.; Takacs, J. M. Curr. Org. Chem. 1999, 3, 497-555.
20. (b) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012-3043.
21. (c) Blackwell, H. E.; O'Leary, D. J.; Chatterjee, A. K.; Washenfelder, R. A.; Bussmann, D. A.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 122, 58-71.
22. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.
23. Pasternak, G. W. Mod. Methods Pharmacol. 1990, 6, 1-17.
24. All configurations are given in the C2 → C8 direction.
25. (a) Cusack, N. J.; Reese, C. B.; Risius, A. C.; Roozpeikar, B. Tetrahedron 1976, 32, 2157-2162.
26. (b) Lacombe, P.; Castagner, Y. G.; Ruel, R. Tetrahedron Lett. 1998, 39, 6785-6786.